Notice of Intent to issue a Sole Source Award for Research and Development of 10, 000 lateral flow devices for pre-clinical and clinical studies to rapidly detect HIV
Closed Pre-Solicitation Posted
- Solicitation number
- 75D30126R73455
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Place of performance
- San Diego, California 92121, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Beacon Scientific Inc. for manufacture of 10,000 lateral flow devices for pre-clinical and clinical studies evaluating rapid HIV detection in point-of-care facilities, with quotations due by June 2, 2026. This is a total small business set-aside.
Beacon Scientific possesses proprietary nanoparticle materials that produce superior results to competing lateral flow assay designs, making it the only source capable of performing the required work under FAR 12.102-1. The contract action is for commercial services classified under NAICS 541714 (Research and Development in Biotechnology, except Nanobiotechnology) and PSC AJ12 (General Science and Technology R&D Services).
This notice of intent is not a competitive solicitation. However, the CDC will consider all quotations and responses received within 15 days of publication; the government reserves sole discretion to determine whether to complete the proposed contract or conduct competitive procurement based on responses received. Information will normally be used only to assess whether competitive procurement is appropriate. Interested parties should submit quotations by email to the contract specialist at zvm0@cdc.gov by June 2, 2026.
Notice text
The Centers for Disease Control and Prevention Division of HIV Prevention intends to award a sole source firm fixed price purchase order to Beacon Scientific INC for the manufacture of 10,000 lateral flow devices to be used in pre-clinical and clinical studies evaluating their performance and utility in rapidly detecting HIV antiretroviral usage in point-of-care facilities. This contract action is for commercial services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102-1. NAICS 541714 – Research and Development in Biotechnology (except Nanobiotechnology). Beacon Scientific has proprietary state of the art nanoparticle materials that produce superior results to other LFA design companies making them the only source capable of performing the required work. This notice of intent is not a request for competitive quotations; however, all Quotations/ responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to complete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist at email zvm0@cdc.gov by 06/02/2026.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity